Micro‐ultrasonography‐ vs MRI ‐targeted biopsy in prostate cancer: Updated systematic review and meta‐analysis

Key Points

• To compare the detection and diagnostic accuracy of micro-ultrasonography-targeted biopsy with MRI-targeted biopsy in prostate cancer.
• Conducted a systematic review and meta-analysis of existing studies.
• Compared detection rates for clinically significant prostate cancer (csPCa) between micro-US-TBx and MRI-TBx.
• Evaluated real-time imaging capabilities and accessibility of micro-US-TBx.
• Micro-US-TBx showed detection rates comparable to MRI-TBx.
• Diagnostic accuracy for csPCa was similar between the two methods.
• Micro-US-TBx has potential workflow advantages due to its real-time capabilities.